Theriva Biologics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2019 | $5.7M | $17.2M | $26.0M |
| FY2020 | $3.2M | $8.4M | $6.2M |
| FY2021 | $5.0M | $70.4M | $67.3M |
| FY2022 | $18.4M | $80.6M | $52.3M |
| FY2023 | $15.5M | $55.2M | $23.2M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2019 | $5.7M | $17.2M | $26.0M |
| FY2020 | $3.2M | $8.4M | $6.2M |
| FY2021 | $5.0M | $70.4M | $67.3M |
| FY2022 | $18.4M | $80.6M | $52.3M |
| FY2023 | $15.5M | $55.2M | $23.2M |